drugset / Trial / NCT00389610
Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer
Phase 2
Completed
56 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI) · collabThe Skip Viragh Foundation · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open label, phase II trial study of adjuvant GVAX pancreas vaccine in patients with pancreatic cancer.
Timeline
- Start
- 2006-09-11
- Primary completion
- 2021-10-11
- Completion
- 2022-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GVAX Pancreas Vaccine | Vaccine | — | Other |